Stryker Corporation SYK
272.36
2.61
0.97%
as of 25 Sep
- Market cap
- $103.9B
- P/E
- 28.0×
Follow SYK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Stryker Corporation (SYK) Return on assets
Stryker Corporation's return on assets over the twelve months to 30 June 2026 was 7.91%, up 0.8 percentage points from fiscal 2025 (7.15%). Over the past ten years it has ranged from 4.79% (fiscal 2017) to 14.4% (fiscal 2018); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of −19.7% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Annual
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 7.15% | (0.07) |
| FY2024 | 7.22% | (1.02) |
| FY2023 | 8.24% | 1.65 |
| FY2022 | 6.59% | 0.81 |
| FY2021 | 5.78% | 0.82 |
| FY2020 | 4.96% | (2.30) |
| FY2019 | 7.26% | (7.12) |
| FY2018 | 14.4% | 9.59 |
| FY2017 | 4.79% | (4.20) |
| FY2016 | 8.99% | 0.40 |
Against its own ten years
Low 4.79%
High 14.4%
Ten-year median
7.22%
Current reading's percentile
45
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.5% |
| BSX Boston Scientific Corporation compare | 8.47% |
| SYK Stryker Corporation | 7.91% |
| STE STERIS plc compare | 7.62% |
| EW Edwards Lifesciences Corporation compare | 7.35% |
| MDT Medtronic PLC compare | 5.68% |
| ABT Abbott Laboratories compare | 5.62% |
| GEHC GE HealthCare Technologies Inc. compare | 5.45% |
| PHG Koninklijke Philips N.V. compare | 4.21% |
| Medical Devices industry median | −19.7% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on SYK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement